These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35990252)

  • 1. Linc00312 Single Nucleotide Polymorphism as Biomarker for Chemoradiotherapy Induced Hematotoxicity in Nasopharyngeal Carcinoma Patients.
    Guo Z; Wang YJ; He BS; Zhou J
    Dis Markers; 2022; 2022():6707821. PubMed ID: 35990252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Polymorphisms of Long Non-coding RNA Linc00312 Are Associated With Susceptibility and Predict Poor Survival of Nasopharyngeal Carcinoma.
    Guo Z; Bao MH; Fan YX; Zhang Y; Liu HY; Zhou XL; Wu B; Lu QQ; He BS; Nan XY; Lu JY
    Front Cell Dev Biol; 2021; 9():698558. PubMed ID: 34336850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma.
    Zhang W; Huang C; Gong Z; Zhao Y; Tang K; Li X; Fan S; Shi L; Li X; Zhang P; Zhou Y; Huang D; Liang F; Zhang X; Wu M; Cao L; Wang J; Li Y; Xiong W; Zeng Z; Li G
    J Mol Histol; 2013 Oct; 44(5):545-54. PubMed ID: 23529758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAX -248 G>A and BCL2 -938 C>A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach.
    Chatterjee K; De S; Deb Roy S; Sahu SK; Chakraborty A; Ghatak S; Das N; Mal S; Roy Chattopadhyay N; Das P; Reddy RR; Mukherjee S; Das AK; Puii Z; Zomawia E; Singh YI; Tsering S; Riba K; Rajasubramaniam S; Suryawanshi AR; Choudhuri T
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1171-1181. PubMed ID: 33906310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional variant in CHK1 contributes to increased risk of nasopharyngeal carcinoma in a Han Chinese population.
    Guo Z; Wang Y; Zhao Y; Jin Y; An L; Xu H; Liu Z; Chen X; Zhou H; Wang H; Zhang W
    J Cell Biochem; 2020 Jun; 121(5-6):3248-3255. PubMed ID: 31904144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Polymorphisms in ERCC1 Gene and Their Association with Response to Radiotherapy in Moroccan Patients with Nasopharyngeal Carcinoma.
    Benzeid R; Gihbid A; Tawfiq N; Benchakroun N; Bendahhou K; Benider A; Guensi A; El Benna N; Filali Maltouf A; Attaleb M; Chaoui I; Khyatti M; El Mzibri M
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):93-99. PubMed ID: 36708557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-stage genome-wide association study identifies novel germline genetic variations in CACNA2D3 associated with radiotherapy response in nasopharyngeal carcinoma.
    Yu LL; Hu BW; Huang HX; Yu B; Xiao Q; Lv QL; Luo CH; Guo CX; Li JG; Xie XX; Yin JY
    J Transl Med; 2023 Jan; 21(1):11. PubMed ID: 36624463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argonaute 2 and nasopharyngeal carcinoma: a genetic association study and functional analysis.
    Li P; Meng J; Zhai Y; Zhang H; Yu L; Wang Z; Zhang X; Cao P; Chen X; Han Y; Zhang Y; Chen H; Ling Y; Li Y; Cui Y; Bei JX; Zeng YX; He F; Zhou G
    BMC Cancer; 2015 Nov; 15():862. PubMed ID: 26545861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma.
    Guo Z; Wang YH; Xu H; Yuan CS; Zhou HH; Huang WH; Wang H; Zhang W
    Cell Death Dis; 2021 Jan; 12(1):69. PubMed ID: 33431817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
    Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of
    Hsu HT; Lu YT; Chen YT; Hsing MT; Su CW; Su SC; Lin CW; Yang SF
    J Cancer; 2024; 15(8):2354-2360. PubMed ID: 38495489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.
    Tsai CW; Tsai MH; Shih LC; Chang WS; Lin CC; Bau DT
    Anticancer Res; 2013 Aug; 33(8):3391-6. PubMed ID: 23898109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients.
    Guo Z; Wang Y; Zhao Y; Jin Y; An L; Wu B; Liu Z; Chen X; Zhou H; Wang H; Zhang W
    Oncotarget; 2017 Sep; 8(37):62286-62297. PubMed ID: 28977945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms within NFKBIA are associated with nasopharyngeal carcinoma susceptibility in Chinese Han population.
    Zhang H; Deng S; Zhang J; Zhu G; Zhou J; Ye W; Wang Q; Wang Y; Zou B; Zhang P; Zhang S; Lang J; Lu S
    Cytokine; 2021 Feb; 138():155356. PubMed ID: 33160813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.
    Tang QN; Liu LT; Qi B; Guo SS; Luo DH; Sun R; Sun XS; Chen DP; Guo L; Mo HY; Wang P; Liu SL; Liang YJ; Li XY; Yang ZC; Chen QY; Mai HQ; Tang LQ
    JAMA Netw Open; 2021 Dec; 4(12):e2138470. PubMed ID: 34928359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Liu H; Qi B; Guo X; Tang LQ; Chen QY; Zhang L; Guo L; Luo DH; Huang PY; Mo HY; Xiang YQ; Qiu F; Sun R; Zhang Y; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Cao KJ; Qian CN; Hong MH; Mai HQ
    PLoS One; 2013; 8(12):e82750. PubMed ID: 24340057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma.
    Lung RW; Wang X; Tong JH; Chau SL; Lau KM; Cheng SH; Woo JK; Woo J; Leung PC; Ng MH; Tang NL; To KF
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E28-38. PubMed ID: 22711332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of toll-like receptor 4 variations on nasopharyngeal carcinoma risk and survival in tunisian population.
    Ben Chaaben A; Ayadi I; Abaza H; Baroudi O; Douik H; Harzallah L; Bouassida J; Bouckouaci W; Guemira F; Mankai A; Kharrat M; Tamouza R
    Tunis Med; 2024 Feb; 102(2):100-106. PubMed ID: 38567476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Functional 5'-UTR Polymorphism of MYC Contributes to Nasopharyngeal Carcinoma Susceptibility and Chemoradiotherapy Induced Toxicities.
    Guo Z; Wang Y; Zhao Y; Jin Y; An L; Xu H; Liu Z; Chen X; Zhou H; Wang H; Zhang W
    J Cancer; 2019; 10(1):147-155. PubMed ID: 30662535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CC-genotype of the cyclooxygenase-2 gene associates with decreased risk of nasopharyngeal carcinoma in a Tunisian population.
    Mamoghli T; Douik H; Mehri S; Ghanem A; Ben Chaabane A; Bouassida J; Kablouti G; Harzallah L; Gritli S; Guemira F
    Pathol Biol (Paris); 2015 Feb; 63(1):7-10. PubMed ID: 25438689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.